Colgate-Palmolive reported stronger-than-expected quarterly results, surpassing Wall Street estimates and raising its annual sales forecast on the back of moderate price hikes and increased advertising spending. The company plans to implement additional price increases to offset rising costs, including the impact of tariffs, which have been putting pressure on its margins. As a strategy to protect its profitability, Colgate is focusing on boosting demand for its oral and personal care products, despite the increased expenses related to marketing and advertising.
Like many consumer goods companies, Colgate is grappling with the effects of tariffs on raw materials, particularly on its toothpastes manufactured in Mexico for the U.S. market. With tariffs expected to raise the company’s cost of goods sold by approximately $200 million in 2025, Colgate is adjusting its pricing strategy to maintain its margins. This increase in tariffs follows the levies recently imposed by the U.S. and China, adding to the broader uncertainty in global markets.
While other major companies in the sector, such as Procter & Gamble and Kimberly-Clark, have issued gloomy annual profit forecasts due to tariff-related uncertainties, Colgate’s outlook is more optimistic. CEO Noel Wallace acknowledged that the ongoing volatility remains challenging, but the company has factored in the tariff impact and now expects low-single-digit percentage growth in annual sales, up from its prior forecast of flat sales.
In the first quarter, Colgate saw a 1.4% increase in organic sales, driven by a 1.5% rise in prices. The company reported net sales of $4.91 billion, surpassing the analyst estimates of $4.87 billion. On an adjusted basis, Colgate earned 91 cents per share, exceeding the average analyst estimate of 86 cents. Its gross profit margin rose by 80 basis points to 60.8%, showing strong financial performance despite external challenges.
Looking ahead, Colgate has revised its annual organic sales growth forecast to between 2% and 4%, down from its previous projection of a 3% to 5% increase. Following the announcement, the company’s shares rose by approximately 1% in premarket trading, reflecting investor confidence in the company’s ability to navigate the pressures of tariffs and rising costs.
READ MORE: